DE60111044D1 - Verwendung von aminen - Google Patents

Verwendung von aminen

Info

Publication number
DE60111044D1
DE60111044D1 DE60111044T DE60111044T DE60111044D1 DE 60111044 D1 DE60111044 D1 DE 60111044D1 DE 60111044 T DE60111044 T DE 60111044T DE 60111044 T DE60111044 T DE 60111044T DE 60111044 D1 DE60111044 D1 DE 60111044D1
Authority
DE
Germany
Prior art keywords
combatting
amines
activation
preventing
kinin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60111044T
Other languages
English (en)
Other versions
DE60111044T2 (de
Inventor
Anne Juelsrud
Gunn Bjerke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Amersham Health AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Health AS filed Critical Amersham Health AS
Application granted granted Critical
Publication of DE60111044D1 publication Critical patent/DE60111044D1/de
Publication of DE60111044T2 publication Critical patent/DE60111044T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Lubricants (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60111044T 2000-03-24 2001-03-22 Verwendung von aminen Expired - Lifetime DE60111044T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0007239 2000-03-24
GBGB0007239.7A GB0007239D0 (en) 2000-03-24 2000-03-24 Use
PCT/NO2001/000123 WO2001072669A2 (en) 2000-03-24 2001-03-22 Therapeutic use of polyhydroxy amine derivates

Publications (2)

Publication Number Publication Date
DE60111044D1 true DE60111044D1 (de) 2005-06-30
DE60111044T2 DE60111044T2 (de) 2006-05-04

Family

ID=9888396

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60111044T Expired - Lifetime DE60111044T2 (de) 2000-03-24 2001-03-22 Verwendung von aminen

Country Status (8)

Country Link
US (1) US7060731B2 (de)
EP (1) EP1282592B1 (de)
JP (1) JP2003528836A (de)
AT (1) ATE296281T1 (de)
AU (1) AU2001252772A1 (de)
DE (1) DE60111044T2 (de)
GB (1) GB0007239D0 (de)
WO (1) WO2001072669A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060100127A1 (en) 2004-11-11 2006-05-11 Meier Ingrid K N,N-dialkylpolyhydroxyalkylamines
US8061515B2 (en) * 2010-02-19 2011-11-22 Michael Carrasquillo Compact disc storage and protective enclosure
CA2997791A1 (en) * 2015-09-30 2017-04-06 Duke University Ascorbate formulations and methods of use as contrast agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2919229A (en) * 1957-11-22 1959-12-29 Us Vitamin Corp N-methylglucamine salts of alphanaphthyl and acyl 1, 3-indandione and methods of using same
US3906109A (en) * 1972-02-09 1975-09-16 Dan Christian Roehm Blood clotting depressant therapy
JPH0678241B2 (ja) * 1986-04-02 1994-10-05 エーザイ株式会社 ｔＰＡ医薬組成物
US5028625A (en) * 1989-06-20 1991-07-02 American Home Products Corporation Acid addition salt of ibuprofen and meglumine
IL98744A0 (en) * 1990-07-06 1992-07-15 Gen Hospital Corp Method of studying biological tissue using monocrystalline particles
JPH09511516A (ja) * 1994-04-12 1997-11-18 カイロサイエンス・リミテッド グルカミン誘導体を用いるエトドラックの分割法
CA2192682A1 (en) * 1994-06-29 1996-01-11 Alfred Sallmann New salts of 2-¬(2,6-dichlorophenyl)amine|phenylacetoxyacetic acid with organic basic cations
AU1885999A (en) * 1998-02-17 1999-08-30 Miciopharma Chemical Aktiengesellschaft A watersoluble nimesulide adduct also for injectable use
US6093743A (en) * 1998-06-23 2000-07-25 Medinox Inc. Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor

Also Published As

Publication number Publication date
DE60111044T2 (de) 2006-05-04
US20030045586A1 (en) 2003-03-06
US7060731B2 (en) 2006-06-13
GB0007239D0 (en) 2000-05-17
AU2001252772A1 (en) 2001-10-08
ATE296281T1 (de) 2005-06-15
EP1282592A2 (de) 2003-02-12
WO2001072669A3 (en) 2002-01-03
WO2001072669A2 (en) 2001-10-04
EP1282592B1 (de) 2005-05-25
JP2003528836A (ja) 2003-09-30

Similar Documents

Publication Publication Date Title
BR9916111A (pt) Derivados de fenilglicina
BR9806752A (pt) Ftalazinonas.
DE59913784D1 (de) Verwendung von Thiazolidinderivaten als antihyperglykämische Mittel
TR200103493T2 (tr) Metaloproteaz önleyicileri
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
DK0670310T3 (da) Bisulfitaddukt af argininaldehyder egnet som thrombininhibitorer og som antikoagulanter
BR0014078A (pt) Inibidores de fator xa
AR023777A1 (es) Nuevos compuestos
BR0110998A (pt) Derivados de fenilglicina
UY27972A1 (es) Derivados de hidantoína
BR0214309A (pt) Derivados aril-1,4-pirazina substituìdos
DK125796A (da) I form af små molekyler foreliggende inhibitorer for rotamaseaktivitet
NO992492L (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
DK0998460T3 (da) Hidtil ukendte tetrazolderivater
BR0209149A (pt) Ftalazinonas
WO2002070469A3 (en) Selective pde3b inhibitors and use of the same in therapy
BR0315662A (pt) Derivados de 1-(4-benzil-piperazin-1-il)-3-fenil-propenona
BR0111158A (pt) Composto e sais fisiológicos do mesmo, método para tratar uma condição mediana por tnf-a em um paciente
DE50109698D1 (de) N-heteroarylmethyl-m-phenylendiamin-derivate enthaltende färbemittel für keratinfasern sowie neue n-heteroarylmethyl-m-phenylendiamin-derivate
ATE296281T1 (de) Verwendung von aminen
DK1015437T3 (da) Benzoxazin- og benzothiazin-derivater og deres anvendelse i lægemidler
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
BR0314139A (pt) Derivados de 1,4-pirazina substituìdos
DK1248651T3 (da) Produkt omfattende en heterotrimer G-proteinsignaltransduktionshæmmer kombineret med et antihypertensivt middel til terapeutisk anvendelse i behandlingen af arteriel hypertension
TR200402322T4 (tr) Triptaz inhibitörler

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: GE HEALTHCARE AS, OSLO, NO

8328 Change in the person/name/address of the agent

Representative=s name: HAMMONDS LLP, LONDON, GB